Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded Last action
- Contract number
- SPE2DR26FGBR7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,708
Award facts
- Contract value 100% obligated
- $1,707.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,707.57 to DMS Pharmaceutical Group Inc. on January 26, 2026, for the supply of TYMLOS 80 MCG Dose Pen Injector (1.56mL). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price contract type with no set-aside designation. The delivery order carries an ultimate completion date of January 27, 2026, with performance taking place at the vendor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy. The underlying prime vendor contract, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue delivery orders for comprehensive pharmaceutical products and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance on numerous prior delivery orders across diverse therapeutic categories demonstrates its capability as a critical pharmaceutical supplier for federal military medical operations.
Quick answers
Who was awarded contract SPE2DR26FGBR7?
SPE2DR26FGBR7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FGBR7 worth?
The government has obligated $1,708 on SPE2DR26FGBR7.
Is contract SPE2DR26FGBR7 an order under another contract?
Yes. SPE2DR26FGBR7 is a delivery order under SPE2DR25D9315, an indefinite delivery contract.
Was contract SPE2DR26FGBR7 competed?
The extent of competition for SPE2DR26FGBR7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award